The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...

Oruka Therapeutics, Inc. announced progress in its clinical programs with ORKA-001 and ORKA-002, targeting chronic skin diseases like psoriasis. The company completed dosing in a Phase 1 trial for ...

As the drug development landscape rapidly evolves, artificial intelligence (AI) is emerging as a transformative force, fundamentally reshaping processes and enhancing efficiencies. This webinar delves ...

Learn how clinical operations leaders can build technology adoption, transform workflows, and cultivate digitally savvy ...

AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety ...

The coronavirus pandemic prompted the speedy development of lifesaving Covid-19 vaccines, showcasing the pharmaceutical industry’s ability to deliver groundbreaking scientific innovations to the ...

Lindus Health and Quotient Sciences have partnered to enable enhanced patient recruitment for Phase I-IIa clinical studies ...

The "In Silico Clinical Trials Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market is undergoing rapid transformation, ...

Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials; Pivotal data from both ROS1 and ALK programs now anticipated in 2025 Initiation of ALKAZAR Phase 3 randomized, ...

Over the past few years, we’ve seen a wave of digital innovation in clinical trials: decentralized models, eConsent, real-time monitoring and direct-to-patient logistics. We’ve digitized nearly every ...

The combination of denifanstat and resmetirom was generally well-toleratedPharmacokinetic (PK) results support further development of the ...